Respiratory distress is a critical condition that can arise from a wide range of acute and chronic pulmonary, cardiac, or systemic disorders, posing immediate threats to oxygenation and overall patient stability. Respiratory distress management focuses on rapid assessment, identification of the underlying cause, and prompt interventions to restore adequate ventilation and oxygen delivery. Initial evaluation includes monitoring oxygen saturation, respiratory rate, blood gas analysis, and hemodynamic status, while imaging and laboratory investigations help determine contributing factors such as infections, airway obstruction, pulmonary edema, or neuromuscular weakness. Interventions may involve supplemental oxygen, non-invasive or invasive ventilation, bronchodilators, diuretics, or targeted pharmacological therapies depending on etiology. Respiratory distress management emphasizes multidisciplinary coordination, with pulmonologists, critical care specialists, nurses, and respiratory therapists collaborating to provide timely, evidence-based care. Early recognition and intervention are crucial in preventing progression to respiratory failure, multi-organ involvement, or long-term pulmonary complications. Patient monitoring continues throughout stabilization, focusing on oxygenation, airway patency, and response to treatment, while education on symptom recognition and adherence to chronic disease management plans supports long-term respiratory health. Advances in bedside monitoring technologies, rapid diagnostics, and personalized therapeutic approaches have improved outcomes and reduced mortality associated with respiratory distress. Effective respiratory distress management integrates swift clinical response, individualized treatment, and continuous evaluation, ensuring both acute stabilization and the prevention of recurrent or worsening respiratory compromise.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation